Riskpilot← Back to searchSign inGet full accessMedoptik Sverige AB
ABActiveOrg 5568047772Traversgatan 12Retail sale of medical and orthopaedic goods · NACE 4774Est. 20101-4 employees
Revenue 2024
SEK 4,3M
-1% vs 2023
EBITDA margin
7.1%
-46% vs 2023
Equity ratio
37.0%
Financial strength
Net profit 2024
SEK 355K
-18% vs 2023
| Revenue | SEK 4,3M | -1% |
| EBITDA | SEK 303K | -46% |
| Net profit | SEK 355K | -18% |
| Total assets | SEK 1,8M | +1% |
| Equity | SEK 650K | -6% |
| Employees | — | — |
Legal name
Medoptik Sverige AB
Org number
5568047772
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
13 april 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva optikerverksamhet, mötesplats för optiker- verksamhet, huvudsakligen på internet, fotografering, handel med värdepapper och därmed förenlig verksamhet.
Address
Traversgatan 12
Phone
+4621130101
Email
peter@vetterskog.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 163 | 4 797 | 4 555 | 4 295 | 4 254 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 474 | 851 | 607 | 562 | 303 |
| Depreciation & amort. | −104 | −99 | −9 | −8 | −0 |
| EBIT | 370 | 752 | 598 | 554 | 303 |
| Net financials | −2 | −1 | −1 | −1 | 88 |
| Profit before tax | 346 | 628 | 451 | 553 | 432 |
| Tax | −76 | −132 | −95 | −118 | −77 |
| Net profit | 270 | 496 | 356 | 435 | 355 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 632 | 1 712 | 1 713 | 1 743 | 1 757 |
| Equity | 783 | 604 | 560 | 695 | 650 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 480 | 616 | 515 | 410 | 511 |
| Total debt | 480 | 616 | 515 | 410 | 511 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20202024
Equity ratio
37.0%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
54.6%
This company
18.4%
Market median
+197% vs market
20202024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20202024
Asset turnover
2.42×
This company
1.12×
Market median
+116% vs market
20202024
Debt / equity
1.70×
This company
0.62×
Market median
-174% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JB Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
GM Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medoptik Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnel Maria Körkkö | Chief Auditor | 0 companies |
| Johanna Britt Cecilia Mossberg | Chief Auditor | 0 companies |
| Andreas Kurt Joakim Vetterskog | Deputy Board Member | 0 companies |
| Karolin Lovisa Cecilia Vetterskog | Board of Directors | 0 companies |
| Peter Johan Ingemar Vetterskog | Chairman | 0 companies |